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An Analysis of Interactions between Fluorescently-Tagged
Mutant and Wild-Type SOD1 in Intracellular Inclusions
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Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer’s Disease Research Center, McKnight Brain
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Abstract
Background: By mechanisms yet to be discerned, the co-expression of high levels of wild-type human superoxide
dismutase 1 (hSOD1) with variants of hSOD1 encoding mutations linked familial amyotrophic lateral sclerosis (fALS) hastens
the onset of motor neuron degeneration in transgenic mice. Although it is known that spinal cords of paralyzed mice
accumulate detergent insoluble forms of WT hSOD1 along with mutant hSOD1, it has been difficult to determine whether
there is co-deposition of the proteins in inclusion structures.
Methodology/Principal Findings: In the present study, we use cell culture models of mutant SOD1 aggregation, focusing
on the A4V, G37R, and G85R variants, to examine interactions between WT-hSOD1 and misfolded mutant SOD1. In these
studies, we fuse WT and mutant proteins to either yellow or red fluorescent protein so that the two proteins can be
distinguished within inclusions structures.
Conclusions/Significance: Although the interpretation of the data is not entirely straightforward because we have strong
evidence that the nature of the fused fluorophores affects the organization of the inclusions that form, our data are most
consistent with the idea that normal dimeric WT-hSOD1 does not readily interact with misfolded forms of mutant hSOD1.
We also demonstrate the monomerization of WT-hSOD1 by experimental mutation does induce the protein to aggregate,
although such monomerization may enable interactions with misfolded mutant SOD1. Our data suggest that WT-hSOD1 is
not prone to become intimately associated with misfolded mutant hSOD1 within intracellular inclusions that can be
generated in cultured cells.
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protein (YFP) [4]. By this method, we can visualize the misfolding of
mutant SOD1 in the formation of inclusion-like structures [4].
Fusions of SOD1 to eGFP have been shown to produce proteins in
which SOD1 dimeric interactions occur, and the enzyme retains
activity [5]. In the present study, we present a comprehensive
assessment of interactions between WT and mutant human hSOD1
proteins in culture cell models of aggregation. Our findings indicate
that such interactions can be influenced by the nature of the
fluorophore tag. In general, the data involving WT hSOD1 fused
with YFP were the least complicated to interpret. The weight of
evidence from our studies argues that, within the short time-frame of
mutant SOD1 aggregation that is modeled in cultured cells, WTSOD1 does not readily interact with misfolded mutant SOD1
within cytosolic inclusions.

Introduction
Mutations in the gene encoding superoxide dismutase 1 (SOD1)
cause ,20% of the cases of familial amyotrophic lateral sclerosis
(fALS). SOD1 is a relatively small enzyme comprised of 153 amino
acids; in its active state the protein homodimerizes to form the
mature enzyme with each subunit binding 1 atom of Zn and 1
atom of Cu [1]. To date more than 165 mutations in more than 75
positions, in the enzyme, have been identified in patients
diagnosed with ALS (http://alsod.iop.kcl.ac.uk/Als/Index.aspx).
Initial work to characterize the impact of disease causing
mutations on the biology of SOD1 demonstrated that interactions
between the normal and mutant proteins occurred [2], but the role
of such interactions in disease pathogenesis was uncertain. One
common feature of mutant SOD1 proteins is that they exhibit a
high tendency to aggregate into high molecular weight structures
that are insoluble in non-ionic detergents [3].
To study interactions between WT and misfolded mutant SOD1,
we have previously used a strategy in which SOD1 is fused in frame
to either red fluorescent protein (turbo RFP) or yellow fluorescent
PLOS ONE | www.plosone.org

Methods
DNA expression plasmids
Expression plasmids that encode wild-type (WT), A4VSOD1,
and G37RSOD1 fused to RFP and YFP have been previously
1
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to YFP did not form such inclusions but instead filled the cell with
diffusely distributed fluorescence (Fig. 1). Fusions of RFP or YFP
with mutant hSOD1 (A4V, G37R, or G85R) produced inclusions
that were morphologically distinct from those of the WTSOD1:RFP proteins (Fig. 1). Inclusions formed by YFP and
RFP fusions to mutant hSOD1 could be described as perinuclear
ring-like or multi-focal structures; we referred to these structures as
possessing a variegated morphology (Table S1).
In a recent study, we demonstrated that we can further
distinguish aggregated SOD1 from soluble protein by treating cells
with saponin (an amphipathic glycoside that creates holes in the
plasma membrane without lysing the cell; for review see [12]). In
all of the experiments that follow, experiments were performed in
pairs in which one culture was treated with saponin before
immunostaining, following a previously published paradigm [6].
Similar to what we previously reported for mutant SOD1 fusions
with YFP [6], the inclusions formed by WT-hSOD1:RFP were
found to remain cell associated after treatment with saponin
(Fig. 2). As previously reported [6], WT-hSOD1-YFP fusions
proteins were completely released by saponin treatment (Fig. 2)
whereas mutant hSOD1 fusions to either RFP or YFP formed
variegated inclusion-like structures that remained cell-associated
after saponin treatment (Fig. 3 example of A4V-hSOD1 fused to
RFP or YFP; Figs. S1 and S2 show data for G37R and G85R
SOD1 variants).
Importantly, the RFP protein was much brighter than the YFP
protein and thus the exposure times were adjusted to capture the
images at equivalent intensities. Typically, images of RFP
fluorescence were captured with exposures of 1/200 to
1/300 sec whereas exposures of YFP fluorescence were 1/20 to
1/30 sec (Fig. 3). We observed that exposure times of up to K to
M sec in the YFP channel were possible for cells expressing RFP
fusions, but at these lengths of exposure some minimal bleedthrough of RFP into the YFP channel was noted (Fig. 3, see YFP
image in row 2). Thus, in experiments in which RFP and YFP
fusion proteins were co-transfected to observe co-localization,
weak signals in the YFP channel upon long exposure should be
viewed with the caveat that some weak bleed-through of very
bright RFP structures was possible.

described [4,6]. These original constructs were generated from an
SOD1:YFP fusion protein cDNA (pPD30.38) that was kindly
provided by Dr. Rick Morimoto (Northwestern University). This
SOD1::eYFP construct contained a 27 bp linker (translated
sequence—LQLKLQASA) between SOD1 and YFP that we
modified to include a Sal1 restriction site (new translated linker
sequence—LQSTLQASA). Our modified SOD1:YFP DNA
fusion construct was then cloned into the mammalian pEF-BOS
expression vector [7]. From this initial SOD1:YFP expression
plasmid, we generated vectors for A4V-hSOD1:YFP and G37RhSOD1:YFP by cloning in PCR amplified cDNA from preexisting pEF.BOS vectors [3,8,9], utilizing an Nco 1 site at the 59
end of the open reading frame and introducing a Sal 1 site at the
39 end of the open reading frame in a manner that eliminated the
stop codon and allowed for joining the SOD1 cDNA in-frame with
YFP [4]. A similar approach was used to create SOD1 fusion
proteins with RFP [Turbo RFP cDNA obtained from the pTRIPZ
empty vector available at Open Biosystems (Huntsville, AL, USA)]
by replacing the YFP tag with the RFP tag. In this way, we created
WT-hSOD1:RFP, A4V-hSOD1:RFP and G37R-hSOD1:RFP
constructs. For the present study, additional constructs were
created by replacing the SOD1 portion of these previously made
constructs with PCR amplified cDNAs for the human SOD1FG50/51EE (engineered monomer [10,11]; abbreviated
hWTSOD1mon) or G85R-hSOD1.

Cell transfections
For cell transfection studies, we used Chinese Hamster Ovary
(CHO) cells because these cells normally show a very flat
morphology with a distinct nucleus and cytoplasm; allowing for
a good visualization of intracellular inclusions. These cells also
show good adherence to culture plates and resist lifting after
saponin treatment. Cells were split into 12-well plates containing
Poly-L-Lysine coated coverslips, and incubated at 37uC with 5%
CO2 for 24 hours. Cells were transiently transfected with the
vectors of interest using Lipofectamine-2000 (single transfections:
500 ng total DNA used; co-transfections: 500 ng of each construct
used). 24 hours after transfection, one set of cells were treated with
0.1% saponin (Fluka/Sigma-Aldrich, St. Louis, Mo) in PBS for 30
minutes. The cells were then rinsed with PBS and fixed in 4%
paraformaldehyde in PBS. A 1:2000 solution of DAPI in PBS was
used to stain nuclei. Coverslips were then mounted on slides for
analysis via fluorescence microscopy.
All single and co-transfections were performed three times.
Each sample was analyzed for the presence and composition of
inclusion-like structures. Representative examples of cells from
each sample were photographed. The camera exposures used to
capture RFP and YFP images in co-transfections were recorded
and compared to single transfections to ensure that the fluorescence from YFP was the result of the intended fluorescent protein
rather than bleed-through from co-expressed RFP.

Results
Visualization of WT and mutant SOD1 interactions in the
formation of intracellular inclusions

Figure 1. Mutant SOD1 fused to either RFP or YFP forms
inclusions with similar morphologies. CHO cells were transiently
transfected with vectors to expression WT and ALS-associated variants
(A4V, G37R, G85R). After 24 hours, the cells were fixed in paraformaldehyde and imaged. The exposure times are noted on the images. WThSOD1:RFP produces round, well defined inclusions. WT-hSOD1:YFP
diffusely fills the cytosol (rounded cell in the image shown). Mutant
SOD1 fused to either RFP or YFP form variegated perinuclear inclusions.
The images shown are representative of 3 independent transfection
experiments, analyzing between 200 and 1,000 individual cells.
doi:10.1371/journal.pone.0083981.g001

To examine interactions between WT and mutant human
SOD1 (hSOD1) in the formation of aberrant aggregate inclusions,
we used a strategy in which variants of hSOD1 were fused to
either RFP or YFP following a previously described approach [4].
As previously described when these proteins were expressed in
HEK293FT cells[4,6], when expressed in CHO cells fusion
proteins of WT-hSOD1 to RFP (WT-hSOD1:RFP) formed large
well delineated cytoplasmic inclusions whereas WT-hSOD1 fused
PLOS ONE | www.plosone.org
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Figure 2. Inclusions formed by WT-hSOD1:RFP are not released by saponin. CHO cells were transiently transfected with expression vectors
for the two SOD1 constructs shown. After 24 hours the cells were treated, or not, with saponin, fixed in paraformaldehyde, and imaged. WthSOD1:YFP is fully releasable by saponin treatment whereas WT-hSOD1:RFP remained cell-associated. The images shown are representative of 3
independent transfection experiments, analyzing between 200 and 1,000 individual cells.
doi:10.1371/journal.pone.0083981.g002

Figure 3. Mutant SOD1 fused to RFP or YFP form similar types of inclusions that resist release by saponin. CHO cells were transiently
transfected with expression vectors for A4V-hSOD1:RFP or A4V-hSOD1:YFP. After 24 hours the cells were treated, or not, with saponin, fixed in
paraformaldehyde, and imaged. Inclusions formed by mutant hSOD1 fused to either RFP or YFP remained cell-associated after saponin treatment.
The images shown are representative of 3 independent transfection experiments, analyzing between 200 and 1,000 individual cells. Similar
observations were made with cells expressing G37R or G85R hSOD1 fused to either RFP or YFP (see Figures S1and S2).
doi:10.1371/journal.pone.0083981.g003

PLOS ONE | www.plosone.org

3

December 2013 | Volume 8 | Issue 12 | e83981

Interactions between WT and Mutant SOD1

and S4). This initial finding suggested that WT-hSOD1 could
potentially interact with misfolded mutant SOD1.
An important feature of the version of RFP that was used for
these constructs is that it is known to dimerize whereas YFP is
primarily monomeric [13]. Thus, the WT-SOD1:RFP fusion
protein was essentially a bivalent molecule in which each entity
in the fusion protein could independently dimerize with its
respective partner. To determine how this bivalency influenced
the ability of WT-SOD1:RFP to form inclusions, we fused the
monomeric variant of WT-SOD1 (SOD1-F50E/G51E; [10,11]
to RFP (WT-hSOD1mon:RFP) and YFP (WT-hSOD1mon:YFP). When expressed at high levels in CHO cells, we found
the WT-hSOD1mon fusions to RFP or YFP remained soluble
and completely releasable by saponin (Fig. 5). Co-expression of
WT-hSOD1mon:RFP with WT-hSOD1:YFP (Fig. 6A; Fig. S5)
or WT-hSOD1mon:RFP with WT-hSOD1mon:YFP (Fig. S5)
did not induce inclusions and both proteins remained soluble in
saponin (Table S2). Similar to WT-hSOD:YFP (see Fig. 4A),
WT-hSOD1mon:YFP did not bind tightly to inclusions
formed by WT-hSOD1:RFP (Fig. 6B; Fig. S6; Table S2).
Collectively, these data suggested that the mutations to monomerize WT-hSOD1 did not induce the protein to form inclusion
aggregates.
To determine the role of normal dimeric interactions between
WT and mutant SOD1 in the formation of mixed aggregates, we
performed a series of experiments in which plasmids encoding
mutant hSOD1 fused to YFP (A4V, G37R, G85R) were cotransfected with plasmids encoding hWTmon-RFP. In these
combinations, the WT-hSOD1mon:RFP adopted the more
variegated inclusion morphology of A4V-hSOD1:YFP structures
with both proteins exhibiting resistance to saponin (Fig. 7; and
Figs. S7 and S8 for examples of WT-hSOD1mon:RFP coexpressed with G37R and G85R-hSOD1 fused to YFP) (Table
S2). These findings suggested that monomerization of WThSOD1 could promote an integral interaction with misfolded
mutant hSOD1.
In experiments in which we reversed the fluorescent tags such
that mutant hSOD1 proteins were fused to RFP (A4V, G37R,
and G85R) and the WT-hSOD1mon or WT-hSOD1 proteins
were fused to YFP, then we observed less robust interactions.
When mutant hSOD1:RFP (A4V, G37R, and G85R) was coexpressed with WT-hSOD1mon:YFP (Fig.8A and Figs. S9–S11)
(Table S3), or when co-expressed with WT-hSOD1:YFP (Fig. 8B
and Figs. S12–S14) (Table S3) the YFP fusion proteins remained
fully releasable by saponin. For comparison, when mutant
hSOD1:RFP fusions were co-expressed with mutant hSOD1:YFP
fusions, we observed completely intermingled aggregates that
were resistant to saponin regardless of whether the two
fluorophores were fused to the same mutant or to different
mutants (Fig. 9; and Figs. S15–S20 for examples of all
combinations) (Table S4). Thus, it seemed that when mutant
SOD1:RFP was co-expressed with WT or WT-SOD1mon YFP
fusion proteins, the two WT:YFP variants interacted only weakly
with mutant SOD1:RFP inclusions. By contrast, the co-mingling
of inclusions formed by mutant SOD1 fused to YFP with mutant
SOD1 fused to RFP indicated that the two fluorophores were
compatible; that is they did not prevent inclusion formation.
Thus the lack of a tight association between WT-hSOD1, or WThSOD1mon, with inclusions formed by mutant SOD1 fused to
RFP could be interpreted as evidence that WT-hSOD1 and
monomeric hSOD1 are not inherently prone to interact with
misfolded mutant SOD1 within inclusions.

Figure 4. Co-expression of WT-hSOD1:RFP with WT and mutant
SOD1 fused to YFP. CHO cells were transiently transfected with
expression vectors for the SOD1 constructs shown. After 24 hours the
cells were treated, or not, with saponin, fixed in paraformaldehyde, and
imaged. A, WT-hSOD1:RFP forms well defined round inclusions that are
not released by saponin. Co-expressed WT-hSOD1:YFP appears to be
closely associated with these inclusions, but after saponin this protein is
released whereas the WT-hSOD1:RFP remains cell associated. B, Mutant
SOD1:YFP appears to be more tightly bound to the surface of inclusions
formed by WT-hSOD1:RFP. At least three independent transfection
experiments were performed and between 200 and 1,000 individual
cells were analyzed in compiling these data.
doi:10.1371/journal.pone.0083981.g004

Analysis of interactions between WT and mutant human
SOD1
In all of the observations that are described below, the outcomes
essentially were largely all or none; meaning that if one of the
expressed RFP tagged SOD1 variants formed an inclusion, then
most inclusions also contained the YFP protein or none contained
it. Similarly if one of the YFP tagged variants of SOD1 formed an
inclusion, then most also contained the RFP tagged protein or
none contained it. Thus, the data were analyzed for morphological
outcomes in assessing whether or not the YFP and RFP tagged
proteins produced inclusions, whether SOD1 variants fused to
these fluorescent proteins co-localized in co-transfection experiments, and whether each of the fluorescent fusion proteins was
resistant to saponin.
In a prior study, we had investigated interactions between WThSOD1:RFP and WTh-SOD1 fused to YFP; observing that it
appeared that WT-hSOD1:YFP was intimately associated with the
large round inclusions formed by WT-hSOD1:RFP [4,6].
However, we now observed that the co-expressed WT-hSOD1:YFP was released by saponin; whereas WT-hSOD1:RFP
inclusions remained behind (Fig. 4A). By contrast, mutant fusion
proteins of SOD1:YFP remained associated with the WThSOD1:RFP inclusion after saponin; appearing to be deposited
on the surface of the WT-hSOD1:RFP structure (Fig. 4B; Fig. S3

PLOS ONE | www.plosone.org

4

December 2013 | Volume 8 | Issue 12 | e83981

Interactions between WT and Mutant SOD1

Figure 5. Experimental monomerization of WT-hSOD1 does not induce inclusion formation. Variants of WT-hSOD1 encoding mutations
at amino acids 50/51 that monomerize the proteins were fused to RFP or YFP. In transiently transfected CHO cells, both variants exhibit a diffuse
distribution in the cell and remain solubilizable by saponin. The images shown are representative of 3 independent transfection experiments,
analyzing between 200 and 1,000 individual cells.
doi:10.1371/journal.pone.0083981.g005

In previous studies, we have used approaches similar to what
were used here to examine interactions between WT and mutant
hSOD1 [4]. In the experimental evolution of our work on SOD1
aggregation in cell culture models, we observed that we could
readily distinguish soluble SOD1 (whether fused to a fluorescent
tag or not) from insoluble aggregated SOD1 by treatment of the
cells with saponin [6]. This molecule interacts with cholesterol to
produce pores in the plasma membrane that allow soluble and
readily diffuse-able proteins to release into the aqueous medium
[14,15]. Thus, saponin treatment allowed us to more rigorously
determine whether WT SOD1 is tightly associated with mutant
SOD1 in aggregates.
From previous work, we knew that expression of a fusion of
mutant hSOD1 to RFP in cultured cells produced inclusions
whereas fusion of WT-hSOD1 to YFP produced a soluble protein
[6]. In prior work, when mutant hSOD1:RFP was co-expressed
with WT-hSOD1:YFP, we observed the two proteins closely
associated in inclusion-like structures [6]. In the present study, we
now show that the WT-hSOD1:YFP that seemed to be associated
with the mutant SOD1 inclusion largely dissociates with saponin
treatment. In co-transfections of WT-hSOD1:RFP with WThSOD1mon:YFP, the YFP signal remained largely diffuse and was
easily released into medium by saponin. These data indicate that
the inclusions formed by mutant-hSOD1:RFP leave the SOD1
component of the protein unavailable for pairing with either native
or monomerized WT-hSOD1 within the YFP fusion protein.
The observation that WT-SOD1:RFP forms inclusions and that
monomerization of the protein by mutation converts the protein to

Discussion
In the present study, we describe a comprehensive assessment of
the behavior of WT and mutant SOD1 fused to RFP and YFP
fluorophores (Table 1). A significant methodological finding was
that the nature of the fluorophore directly impacted the behavior
of the protein. Despite this problem, there were some consistent
observations. 1) SOD1 encoding mutations linked fALS and fused
to either RFP or YFP produced inclusion like structures that do
not readily diffuse out of permeabilized cells. 2) Monomerizing
mutations in SOD1 do not induce inclusion formation. 3) SOD1
proteins encoding different fALS mutations can readily form
intermingled inclusions containing both proteins. The less
consistent outcomes involved examinations of interactions between
WT and mutant SOD1. WT-hSOD1:YFP fusion proteins failed to
show strong interactions with misfolded mutant SOD1:RFP within
inclusions. However, WT-hSOD1:RFP, which formed large
round inclusions on its own, appeared to co-aggregate with
mutant SOD1:YPF concentrated at the margin of the RFP
containing structure. We could accept the argument that the
apparent interaction between WT-hSOD1:RFP and misfolded
mutant SOD1 fused to YFP is indicative that the potential does
exist for WT and mutant SOD1 to interact in the formation of
inclusions. However, we view the combinations of mutant SOD1
fused to RFP with WT SOD1 fused to YFP as being more
informative as to how soluble WT-hSOD1 may behave in the
presence of an aggregating mutant SOD1 protein.

PLOS ONE | www.plosone.org
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Figure 7. Co-expression of WT-hSOD1mon:RFP with mutant
hSOD1 fused to YFP. Representative image of cells co-expressing
WT-hSOD1mon:RFP and A4V-hSOD1:YFP. Images showing cell coexpressing WT-hSOD1mon:RFP with G37R- or G85R-hSOD1:YFP are
provided in Figures S7 and S8. Cells were fixed and imaged 24 hours
post-transfection with or without prior treatment with saponin. At least
three independent transfection experiments were performed and
between 200 and 1,000 individual cells were analyzed in compiling
these data.
doi:10.1371/journal.pone.0083981.g007

Figure 6. Co-expression of WT-hSOD1mon:RFP with WThSOD1 and WT-hSOD1mon fused to YFP. CHO cells were
transiently transfected with expression vectors for the SOD1 constructs
shown. After 24 hours the cells were treated, or not, with saponin, fixed
in paraformaldehyde, and imaged. A, Co-expression of WT-hSOD1:RFP
with either WT-hSOD1:YFP or WT-hSOD1mon:YFP does not produce
inclusions; all proteins remain soluble in saponin. B, WT-hSOD1:RFP coexpressed with WT-hSOD1mon:YFP demonstrates a lack of tight
binding between these proteins. At least three independent transfection experiments were performed and between 200 and 1,000
individual cells were analyzed in compiling these data.
doi:10.1371/journal.pone.0083981.g006

for WT-hSOD1:RFP inclusion. However, morphologically, WThSOD1:RFP inclusions were distinct from the inclusions produced
by mutant hSOD1:RFP fusions; and additionally, the morphology
of the mutant hSOD1:YFP fusions (YFP is monomeric [13])
matched that of the mutant hSOD1:RFP fusions. We also

a soluble molecule has implications in our interpretation of data
derived from mutant hSOD1 fused to RFP. The RFP molecule is
known to dimerize and thus the WT-SOD1:RFP proteins possess
two elements that dimerize; the SOD1 domain and the RFP
domain [13]. Experimental conversion of SOD1 from a dimeric to
a monomeric enzyme by the mutation of residues 50 and 51 from
FG to EE was first described by Bertini et al [10]. It is thought that
the introduction of charged residues at these sites produces a
repulsive effect as the two monomers of SOD1 attempt to align as
a homodimeric enzyme [10,11]. These monomeric enzymes retain
activity and crystal structures of this experimental variant have
demonstrated that the monomeric proteins fold into a near normal
conformation [11]. Thus, the engineered monomer of SOD1 is
thought to be WT-like in its properties. Our observation that
hWTmon:RFP proteins remain fully soluble suggests to us that the
formation of aggregates by WT-SOD1:RFP may be occurring by
a process that is unrelated to SOD1 misfolding but rather
potentially due to the formation of interconnected networks
between what are essentially bivalent proteins.
Although the RFP tag clearly altered the behavior of WThSOD1, it is less certain as to whether the tag influenced the
behavior of mutant hSOD1. All three of the hSOD1 mutants we
fused to RFP probably retain the ability to homodimerize and thus
inclusions formed by A4V, G37R, or G85R-hSOD1 fused to RFP
could also include bivalent interactions similar to what we propose
PLOS ONE | www.plosone.org

Figure 8. Co-expression of mutant hSOD1:RFP with WThSOD1mon:YFP or WT-hSOD1:YFP. CHO cells were transiently
transfected with expression vectors for the SOD1 constructs shown.
After 24 hours the cells were treated, or not, with saponin, fixed in
paraformaldehyde, and imaged. A and B, Mutant SOD1:RFP produces
inclusions that only weakly bind WT-hSOD1mon:YFP or WT-hSOD1:YFP.
At least three independent transfection experiments were performed
and between 200 and 1,000 individual cells were analyzed in compiling
these data.
doi:10.1371/journal.pone.0083981.g008
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soluble proteins whether fused to RFP or YFP. On face value, the
data indicate that monomeric WT-hSOD1 can more readily
interact with misfolded mutant SOD1 in the formation of
inclusions. However, we cannot be certain of this conclusion
because the supporting data draw heavily on the behavior of the
RFP fusion proteins. Importantly, we observed that neither WThSOD1:YFP nor WT-hSOD1mon:YFP associated with the
inclusions formed by mutant SOD1:RFP fusion proteins in a
saponin-resistant manner. The lack of agreement between these
sets of experiments complicates interpretation of the data as to
whether monomerization of WT SOD1 facilitates an association
with mutant SOD1 in inclusions. In one condition we see an
association, but the effect was inconsistent.

Conclusions
Our findings clearly show that fluorescent proteins tags that are
commonly used to track the behavior of proteins in living cells are
not completely benign markers. That said; our data indicate that
YFP is probably less intrusive than RFP. In this comprehensive set
of experiments in which we have performed all combinations of
tagging, we find several consistent features. First, mutant SOD1
fusion to either RFP or YFP produced inclusion-like structures.
Second, experimental mutations that monomerize SOD1 do not
heighten its propensity to form inclusions. Third, SOD1 proteins
encoding different fALS mutations can readily form intermingled
inclusions containing both proteins. Because WT-hSOD1 fused to
RFP formed inclusions on its own, we do not view the association
of this protein with inclusions formed by mutant SOD1 fused to
YFP as being informative. Instead we are inclined to place greater
weight on the studies in which mutant SOD1 fused to RFP was cotransfected with WT-hSOD1 fused to YFP. If we focus on these
data, it appears that in our cultured cell models of aggregation
WT-hSOD1 is not highly prone to interact with misfolded mutant
SOD1 in the formation of inclusions. Additionally, mutations that
monomerize WT-hSOD1 do not consistently promote interaction
with mutant SOD1 in inclusions. From these data, we predict that
WT-hSOD1 may be relatively slow to interact with misfolded
mutant SOD1. The much longer timelines of mutant SOD1
misfolding and aggregation that occur in vivo, however, clearly
changes the dynamics of what could happen.

Figure 9. Co-expression of mutant hSOD1 fused to RFP with
mutant hSOD1 fused to YFP. In a matrix approach, all possible
combinations for the 6 fusion constructs of mutant SOD1 fused to RFP
or YFP were examined. In all cases, inclusions contained both proteins
in saponin-resistant aggregates. At least three independent transfection
experiments were performed and between 200 and 1,000 individual
cells were analyzed in compiling these data.
doi:10.1371/journal.pone.0083981.g009

observed that co-expression of different mutant hSOD1 variants
fused to RFP and YPF (e.g. A4V-hSOD1:RFP with G37RhSOD1:YFP) produced completely comingled inclusions for every
possible combination. Collectively, these observations suggest that
the RFP tag exerted little if any impact on the misfolding of
mutant SOD1. Thus, we are inclined to conclude that mutant
SOD1 tagged with RFP is a useful reporter and thus we view the
failure of WT-hSOD1:YFP to interact with inclusions formed by
these RFP tagged proteins as highly suggestive evidence that WThSOD1 is not very prone to co-aggregate with mutant SOD1.
For the monomeric variants of WT-hSOD1, the picture is more
complicated. Although monomeric hSOD1 did not readily
aggregate, WT-hSOD1mon:RFP was capable of fully co-mingling
with mutant SOD1:YFP proteins in saponin resistant inclusions.
Notably, the monomeric variants of WT-hSOD1 behaved as fully

Table 1. Matrix table to summarize morphology of inclusions in cells expressing RFP and YFP tagged variants of SOD1.

Co-transfected
construct

none

none
WT-hSOD1:RFP

Round saponin
resistant inclusions

WT-hSOD1mon:RFP No inclusions
A4V-hSOD1:RFP

WT-hSOD1:YFP

WT-hSOD1mon:YFP

A4V-hSOD1:YFP

No inclusions

No inclusions

Variegated saponin resistant inclusions

Round intermingled
inclusions only RFP
inclusions are
saponin resistant

Round RFP only inclusions.
Only RFP inclusions are
saponin resistant

Round inclusions with the YFP fusion appearing to be layered on the
surface of the RFP structure. Both RFP and YFP fusion proteins in these
inclusions are saponin resistant

No inclusions

No inclusions

Variegated intermingled inclusions; both RFP and YFP inclusions are
saponin resistant

Variegated saponin RFP variegated
resistant inclusions inclusions; only
RFP inclusions are
saponin resistant

G37R-hSOD1:YPF

G85R-hSOD1:YFP

RFP variegated inclusions
only RFP is saponin resistant

G37R-hSOD1:RFP
G85R-hSOD1:RFP
doi:10.1371/journal.pone.0083981.t001
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Representative images from cells co-expressing
A4V-hSOD1:RFP and A4V-hSOD1:YFP or G37R:hSOD1:YFP.
(PDF)

Figure S15

Supporting Information
Representative images from cells expressing G37RhSOD1:RFP or G37R-hSOD1:YFP.
(PDF)
Figure S2 Representative images from cells expressing G85RRhSOD1:RFP or G85R-hSOD1:YFP.
(PDF)
Figure S3 Representative images from cells co-expressing WThSOD1:RFP and A4V-hSOD1:YFP; and cells co-expressing WThSOD1:RFP and G37R-hSOD1:YFP.
(PDF)
Figure S4 Representative images from cells co-expressing WThSOD1:RFP and G85R-hSOD1:YFP.
(PDF)
Figure S1

Representative images from cells co-expressing
A4V-hSOD1:RFP and G85R:hSOD1:YFP.
(PDF)

Figure S16

Representative images from cells co-expressing
G37R-hSOD1:RFP and A4V-hSOD1:YFP or G37R-hSOD1:YFP.
(PDF)

Figure S17

Representative images from cells co-expressing
G37R-hSOD1:RFP and G85R-hSOD1:YFP.
(PDF)

Figure S18

Representative images from cells co-expressing
G85R-hSOD1:RFP and A4V-hSOD1:YFP or G37R-hSOD1:YFP.
(PDF)

Figure S19

Figure S5 Representative images from cells co-expressing WT-

hSOD1mon:RFP and WT-hSOD1:YFP; and cells co-expressing
WT-hSOD1mon:RFP and WT-hSOD1mon:YFP.
(PDF)

Representative images from cells co-expressing
G85R-hSOD1:RFP and G85R-hSOD1:YFP.
(PDF)

Figure S20

Figure S6 Representative images of cells co-expressing WT-

hSOD1:RFP and WT-hSOD1mon:YFP.
(PDF)

Table S1 Behavior of WT and mutant hSOD1 fused to RFP or

Figure S7 Representative images from cells co-expressing WT-

YFP in CHO cells. This table summarizes our observations of the
morphology of YFP fluorescence for fusion proteins expressed in
CHO cells.
(PDF)

hSOD1mon:RFP and G37R-hSOD1:YFP.
(PDF)
Figure S8 Representative images from cells co-expressing WThSOD1mon:RFP and G85R-hSOD1:YFP.
(PDF)

Table S2 Behavior of WT-hSOD1:RFP or WT-hSOD1-

mon:RFP with WT or mutant SOD1:YPF.
(PDF)

Figure S9 Representative images from cells co-expressing A4V-

hSOD1:RFP and WT-hSOD1mon:YFP.
(PDF)

Table S3 Behavior of WT-hSOD1:YFP and WT-hSOD1mon:YFP with mutant SOD1:RFP.
(PDF)

Representative images from cells co-expressing
G37R-hSOD1:RFP and WT-hSOD1mon:YFP.
(PDF)

Figure S10

Table S4 Behavior of co-expressed mutant hSOD1:RFP with
mutant hSOD1:YFP.
(PDF)

Representative images from cells co-expressing
G85R-hSOD1:RFP and WT-hSOD1mon:YFP.
(PDF)

Figure S11
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